International Journal of Molecular Sciences· 2026Q1
Topographic Expression of IL-1β and Inflammasome-Associated Proteins in Lesional, Perilesional, and Distant Hidradenitis Suppurativa Skin
- 0citations
- Q1SCImago
- 2026year
Short summary
In hidradenitis suppurativa (HS), IL-18 expression is significantly higher in lesional skin (0 cm) compared to distant uninvolved skin (10 cm) (q=0.0444). Additionally, IL-1β expression is consistently higher in perilesional skin (2 cm) than distant skin (10 cm) across 93% of patients, suggesting a perilesional inflammatory field.
AI-generated from the title and abstract; the full text is not read.
Key points
- IL-18 expression is significantly higher in lesional HS skin (0 cm) than in distant uninvolved skin (10 cm) (q=0.0444).
- IL-1β expression is consistently higher in perilesional HS skin (2 cm) compared to distant uninvolved skin (10 cm) in 7/8 biologic-untreated and 6/6 adalimumab-treated patients.
- This perilesional-to-distant IL-1β pattern was observed in 13/14 patients (92.9%) and remained statistically significant after correction (q4=0.0168).
- Total NLRP3 and caspase-1 did not show robust FDR-adjusted spatial variation across lesional, perilesional, and distant skin.
AI-generated from the title and abstract; the full text is not read.
Abstract
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease characterized by recurrent nodules, abscesses, draining tunnels, and scarring. Dysregulated IL-1 and inflammasome-associated pathways have been implicated in its pathogenesis, but their spatial distribution beyond clinically apparent lesions remains incompletely characterized. To assess topographic expression of NLRP3, caspase-1, IL-1β, and IL-18 across lesional, perilesional, and distant HS skin. Skin samples were obtained from eight biologic-untreated patients with HS, six patients receiving adalimumab, and five healthy controls. In HS, matched 6 mm full-thickness biopsies were obtained from the same axilla at an active inflammatory lesion (0 cm), clinically normal-appearing skin 2 cm from the visible lesion edge, and clinically uninvolved skin 10 cm from the lesion edge. Protein abundance was assessed by Western blot. Primary topographic effects were evaluated using mixed-design ANOVA with Benjamini–Hochberg FDR correction, supplemented by non-parametric and exploratory contrast analyses. No protein showed an FDR (false discovery rate)-significant overall site effect or cohort × site interaction in the primary analysis. In biologic-untreated HS, IL-18 showed an FDR-significant topographic effect (q = 0.0444), with higher expression at 0 cm than at 10 cm (q = 0.0469). An exploratory post hoc 2-versus-10 cm analysis identified a highly concordant IL-1β pattern: expression was higher at 2 cm in 7/8 biologic-untreated and 6/6 adalimumab-treated patients. Fisher’s combined probability remained significant after BH correction across the four proteins evaluated for this contrast (p = 0.00421, q4 = 0.0168), whereas comprehensive correction across all 12 protein × contrast combinations yielded q12 = 0.0505 and did not meet q < 0.05. Overall, 13/14 patients showed the same direction (92.9%; exact 95% CI 66.1–99.8%). IL-18 provided the clearest FDR-supported secondary topographic finding. IL-1β showed a highly concordant but hypothesis-generating perilesional-to-distant spatial pattern, whereas total NLRP3 and caspase-1 did not show robust FDR-adjusted spatial variation.
The authors' abstract, as published at the source. International Journal of Molecular Sciences, 2026 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Dermatology
DermatologyMedicine